Newsletter Archive

91. 12.12.24 -- All Eyes On Sustainability 12/12/2024

    12/12/24 Life Science Leader Newsletter

92. 12.12.24 -- Start Right: Biologics Breakthroughs Begin With Expert Cell Line Development 12/12/2024

    12/12/24 Life Science Leader Newsletter

93. 12.11.24 -- The FDA's Psychedelic Reckoning 12/11/2024
    12/11/24 Life Science Leader Newsletter
94. 12.10.24 -- Unlock Hidden Potential For Growth With Advanced Biologics Capabilities 12/10/2024
    12/10/24 Life Science Leader Newsletter
95. 12.09.24 -- Companies To Watch: Terns Pharmaceuticals 12/9/2024
    12/09/24 Life Science Leader Newsletter
96. 12.06.24 -- What Will The Incoming Trump Administration Mean For Drug Patents? 12/6/2024
    12/06/24 Life Science Leader Newsletter
97. 12.04.24 -- How To Lead a Company That's Disrupting An Industry 12/4/2024
    12/04/24 Life Science Leader Newsletter
98. 12.04.24 -- Developability Strategies That Improve Biologic Development 12/4/2024

    12/04/24 Life Science Leader Newsletter

99. 12.02.24 -- Translating Hidden Gems Into Medicines 12/2/2024
    12/02/24 Life Science Leader Newsletter
100. 11.27.24 -- CEO Panel Talks IRA Impact At Galien Forum 11/27/2024
     11/27/24 Life Science Leader Newsletter